The share of corresponding/leading authors in scientific publications in drug discovery in Brazil is projected to decline gradually from 93.57% in 2024 to 93.11% in 2028. This marks a steady decrease, indicating a slight downward trend in the dominance of Brazilian authorship. In 2023, the corresponding figure stood at a similar range, suggesting a stable yet declining pattern. Annual changes are minor, with the percentage decrease remaining consistently below 0.15% year-on-year, indicating a stable market with minimal fluctuations.
Future trends to watch for include the potential for international collaborations, which could further diversify authorship. Additionally, shifting research priorities or increased investments in R&D might alter the landscape, impacting authorship shares in the coming years.
